Report of the 7th International Conference on Relapse After Transplant and Cellular Therapy (HSCT²)
… post-allo-HSCT using cellular or targeted interventions. Diseases in focus: AML, MDS, Myelofibrosis, ALL, B cell and … advances may facilitate a transition toward peripheral blood–based MRD monitoring in AML, potentially reducing the … Leukemia Who Are Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA)” . TSC-101 is a …